Authors: |
Linda Russell (on behalf of the UK investigators) |
Background: |
This study presents the preliminary findings of UK data from a larger international
outcomes evaluation of a silver-releasing foam dressing, Contreet Foam Dressing™ (manufactured
by Coloplast A/S). |
Objective: |
To carry out a comparative outcomes assessment of clinical performance
of Contreet Foam vs local best practice in the treatment of chronic wounds. |
Method: |
This study was
comparative, open, prospective, parallel, and block-randomised. A total of 82 patients were included
and were recruited from chronic wound clinics. Patients were randomised to a 4-week treatment
period with either Contreet Foam or local best practice. |
Results: |
Findings indicate that Contreet
Foam has greater ease of application and removal (p=0.0003), enhanced fluid absorption (32% vs 56%
leakage), leakage control (p=0.0032), odour reduction, and prolonged wear time (4.2 vs 3.4 days), and
a 50% relative reduction in wound area from baseline during the study. |
Conclusion: |
These preliminary
results support faster wound healing with Contreet Foam vs best local practice. |
